| abstract |
The compounds of formula I, or a pharmaceutically acceptable salt thereof, can modulate the production of the body's cyclic guanosine monophosphate ("cGMP") and may be suitable for the therapy and prevention of diseases associated with disturbed cGMP balance. In addition, the invention relates to a process for the preparation of a compound of formula I or a pharmaceutically acceptable salt thereof, to the therapy and prevention of the above-mentioned diseases and to the use of such compounds for the manufacture of a medicament for this purpose, To a pharmaceutical composition comprising a pharmaceutically acceptable salt thereof. (I) |